After Hours Summary: MU -2.6% falls on earnings; FDA recommends inclusion of Omicron BA.4/5 component for COVID-19 vaccine booster dosesAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: ACCD +0.1%
Companies trading higher in after hours in reaction to news: TAK +0.9% (lanadelumab demonstrates positive results in the prevention of HAE Attacks in Phase 3 Trial), SKLZ +0.8% (names new CFO), NVTA +0.8% (PACB and NVTA amend development and commercialization agreement), JBLU +0.4% (JBLU extends tender offer to SAVE to July 29), CBL +0.4% (re-establishes regular quarterly dividend), PACB +0.2% (PACB and NVTA amend development and commercialization agreement)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: MU -2.6%, SJR -0.1%
Companies trading lower in after hours in reaction to news: CLDX -3.6% (presents interim data from Barzolvolimab Phase 1b Study), WDC -3.2% (in sympathy with MU earnings), PCT -2.3% (CEO to resign; current COO promoted to CEO), ACRE -1.6% (files for $1.25 bln mixed securities shelf offering), ERJ -1.3% (signs agreement with Toyota do Brasil in order to run operations more efficiently), EDR -1.2% (LNW amends purchase agreement for sale of OpenBet to EDR), SAVE -1% (JBLU extends tender offer to SAVE to July 29), MRNA -0.8% (FDA recommends inclusion of Omicron BA.4/5 component for COVID-19 vaccine booster doses), LULU -0.6% (files mixed securities shelf offering), PFE -0.5% (FDA recommends inclusion of Omicron BA.4/5 component for COVID-19 vaccine booster doses), EMR -0.4% (acquires Fluxa to complement its software portfolio), INTC -0.4% (Sen McConnell tweets saying there will be no bipartisan USICA as long as Dems pursue a partisan reconciliation bill), JNJ -0.3% (FDA recommends inclusion of Omicron BA.4/5 component for COVID-19 vaccine booster doses), F -0.2% (to recall more than 63,000 Bronco SUVs and Ranger pickup trucks for windshield issue, according to Consumer Reports), BNTX -0.2% (FDA recommends inclusion of Omicron BA.4/5 component for COVID-19 vaccine booster doses), FTCV -0.2% (FTCV and EToro plan to let deadline for merger pass without closing deal, according to The Information), LMT -0.1% (awarded $307 mln Army contract)